Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours

Tumor Heterogeneity in Breast Cancer

(2015) Sunil Badve et al.   ADVANCES IN ANATOMIC PATHOLOGY

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

(2015) A. S. Coates et al.   ANNALS OF ONCOLOGY

Strategies for developing Ki67 as a useful biomarker in breast cancer

(2015) Carsten Denkert et al.   BREAST

The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer

(2015) Matthias Christgen et al.   HUMAN PATHOLOGY

Ki67 Heterogeneity in Estrogen Receptor–Positive Breast Cancers

(2015) Takanori Himuro et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Clinical management of breast cancer heterogeneity

(2015) Dimitrios Zardavas et al.   Nature Reviews Clinical Oncology

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

(2015) Charlotte KY Ng et al.   GENOME BIOLOGY

Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases

(2014) Lik Hang Lee et al.   Scientific Reports

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

(2013) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

From genome to bedside: Are we lost in translation?

(2013) Daniel F. Hayes   BREAST

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

(2013) Gaetano Aurilio et al.   EUROPEAN JOURNAL OF CANCER

Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance

(2012) Hyesil Seol et al.   MODERN PATHOLOGY

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

(2012) Zsuzsanna Varga et al.   PLoS One

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies

(2011) Quinci Romero et al.   BMC CANCER

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute